Please create an account to participate in the Slashdot moderation system

 



Forgot your password?
typodupeerror
Medicine Science

HIV Vaccine Safe Enough To Pass Phase 1 Human Trials 141 141

An anonymous reader sends this excerpt from Western University in Canada: "The first human applied clinical study (SAV CT 01) using a genetically modified killed whole-virus vaccine (SAV001-H) to evaluate its safety and tolerability was initiated in March 2012. This study is a randomized, observer-blinded, placebo-controlled study of killed whole HIV-1 vaccine (SAV001-H) following intramuscular (IM) administration. Infected men and women, 18-50 years of age, have been enrolled in this study and randomized into two treatment groups to administer killed whole HIV-1 vaccine (SAV001-H) or placebo. Sumagen announced today the patient enrollment has progressed smoothly and there have been no adverse effects observed including local reactions, signs/symptoms and laboratory toxicities after SAV001-H injection in all enrolled patients to date. With these interim results, the SAV001-H has proven safety and tolerability in humans and given Sumagen confidence for the next clinical trials to prove its immunogenicity and efficacy evaluation."
This discussion has been archived. No new comments can be posted.

HIV Vaccine Safe Enough To Pass Phase 1 Human Trials

Comments Filter:

FORTUNE'S FUN FACTS TO KNOW AND TELL: A giant panda bear is really a member of the racoon family.

Working...